Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORZA: Formoterol-beclomethasone for Cough in Non-CF Bronchiectasis
NCT03846570Phase 3Terminated
- Sponsor
- Erasmus MC
- Start
- Jan 2019
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of beclomethasone, formoterol in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Erasmus MC. Started Jan 2019; status: terminated.
02
Drugs
beclomethasoneformoterol
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT03846570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03846570.